Home › Myasthenia Gravis › California › San Francisco
Myasthenia Gravis clinical trials in San Francisco, CA
6 studies for Myasthenia Gravis are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- University of California, San Francisco, San Francisco
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
RecruitingObservational studyHealthy volunteers welcome
- University of California-San Francisco, San Francisco
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- UCSF Benioff Children's Hospital, San Francisco
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingPhase 3
- Site Number - 1004, San Francisco
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
RecruitingPhase 3
- University of California San Francisco (UCSF), San Francisco
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
RecruitingObservational study
- UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,, San Francisco
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Milwaukee, WI7 studies
- New York City, NY7 studies
- Miami, FL7 studies
- St. Louis, MO7 studies
- Columbia, MO6 studies
- Charleston, SC6 studies
- Washington, DC6 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer29 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Colorectal Cancer19 studies
- Cardiovascular Disease18 studies
- Ovarian Cancer18 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.